Oblita
  • About us
    • Who we are
    • Our focus
    • Our motivation
    • How we work
    • Contact us
  • Team
    • Leadership Team
    • Scientific Advisory Board
    • Board of Directors
  • Product
    • D121
  • Global Health
    • Commitment
    • Priority Review Voucher
    • Canine Leishmaniasis
    • Leishmaniasis in humans
    • Chagas Disease
    • Invasive fungal infections
    • Cryptosporidiosis
  • Investors
  • News
Select Page

Iran suffers from a high incidence of cutaneous leishmaniasis (CL)

Full article EN (.pdf)

© Oblita Therapeutics – global health research & development

TT4CL

  • Follow
  • Follow